Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company. The dividend is payable on August 1, 2024, to stockholders of record at the close of business on July 5, 2024.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on September 3, 2024, to stockholders of record at the close of business on August 6, 2024.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and Instagram.

corporatefinancial-news

For more information, contact: Media: media@bms.com Investors: investor.relations@bms.com

Bristol Myers Squibb (NYSE:BMY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Bristol Myers Squibb 차트를 더 보려면 여기를 클릭.
Bristol Myers Squibb (NYSE:BMY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Bristol Myers Squibb 차트를 더 보려면 여기를 클릭.